Chris VanDeusen, Ph.D.

Chief Scientific Officer

Chris VanDeusen, Ph.D. brings more than 15 years of experience in the biopharmaceutical sector, with extensive expertise in drug discovery and development having contributed to or been the inventor of multiple compounds entering into pre-clinical development.  Previously, Dr. Van Deusen was the head of the Chemistry division within Tissue Protection and Repair at Sanofi and Genzyme, leading global project teams in the areas of inflammation and fibrosis.  Dr. Van Deusen earned a BA in Chemistry from Wittenberg University and a PhD from Stanford University.